News | Cardiovascular Surgery | May 01, 2017

ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology

System with Active Clearance Technology helps reduce the occurrence of chest tube occlusions following cardiac surgery

ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology

May 1, 2017 — ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The award was presented to ClearFlow for its development of the PleuraFlow Active Clearance Technology (ACT) System, which has been clinically shown to reduce the occurrence of complications after cardiac surgery, according to the company.

Evidence suggests that chest tubes used for drainage after cardiac surgery have a high failure rate due to clogging. If the extra blood is not removed from inside the chest cavity after surgery, patients may require additional procedures, which are known as retained blood syndrome (RBS). Multiple studies have shown that retained blood has a statistically significant negative impact on cardiac surgery patients after surgery, including a higher likelihood of mortality, longer ICU and hospital lengths of stay, four times higher infection rates and increased cost of care.

ClearFlow’s PleuraFlow ACT System is the only U.S. Food and Drug Administration (FDA)-cleared device available, according to ClearFlow, that enables caregivers to proactively prevent or minimize chest tube occlusions and reduce retained blood.

Announcing ClearFlow as the recipient of the award in the ‘New Product Innovation’ category, Frost & Sullivan referred to PleuraFlow as a “transformational force in post-operative cardiothoracic surgery protocols.”

“Clearly, the PleuraFlow ACT System is uniquely positioned for sustained success as it meets customers’ core requirements of quality, functionality and reliability,” remarked Frost & Sullivan Senior Industry Analyst Patrick Riley.

Each year, Frost & Sullivan presents this award to the company that develops an innovative product to leverage leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers.

The PleuraFlow Active Clearance Technology System is approved for use in the United States, Europe, Australia, Brazil, Canada, and other countries in Asia and the Middle East.

For more information: www.clearflow.com

Related Content

Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
Sponsored Content | Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery| May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery| May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery| May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery| May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
Overlay Init